185 related articles for article (PubMed ID: 8951884)
1. Opposite role of delta 1- and delta 2-opioid receptors activated by endogenous or exogenous opioid agonists on the endogenous cholecystokinin system: further evidence for delta-opioid receptor heterogeneity.
Noble F; Fournie-Zaluski MC; Roques BP
Neuroscience; 1996 Dec; 75(3):917-26. PubMed ID: 8951884
[TBL] [Abstract][Full Text] [Related]
2. Role of endogenous cholecystokinin in the facilitation of mu-mediated antinociception by delta-opioid agonists.
Noble F; Smadja C; Roques BP
J Pharmacol Exp Ther; 1994 Dec; 271(3):1127-34. PubMed ID: 7996417
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of adenylyl cyclase activity by mu and delta opioids in rat caudate putamen and nucleus accumbens.
Izenwasser S; Búzás B; Cox BM
J Pharmacol Exp Ther; 1993 Oct; 267(1):145-52. PubMed ID: 7901389
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of D1 dopamine receptor- and of A2a adenosine receptor-stimulated adenylyl cyclase by mu-, delta 1-, and delta 2-opioid agonists in rat caudate putamen.
Noble F; Cox BM
J Neurochem; 1995 Jul; 65(1):125-33. PubMed ID: 7790855
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of delta-opioid receptors reduces the in vivo binding of the cholecystokinin (CCK)-B-selective agonist [3H]pBC 264: evidence for a physiological regulation of CCKergic systems by endogenous enkephalins.
Ruiz-Gayo M; Durieux C; Fournié-Zaluski MC; Roques BP
J Neurochem; 1992 Nov; 59(5):1805-11. PubMed ID: 1357099
[TBL] [Abstract][Full Text] [Related]
6. Evidence for delta opioid receptor subtypes regulating adenylyl cyclase activity in rat brain.
Búzás B; Izenwasser S; Portoghese PS; Cox BM
Life Sci; 1994; 54(7):PL101-6. PubMed ID: 8309345
[TBL] [Abstract][Full Text] [Related]
7. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.
Noble F; Cox BM
Br J Pharmacol; 1996 Jan; 117(1):161-9. PubMed ID: 8825358
[TBL] [Abstract][Full Text] [Related]
8. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
9. Systemic administration of (Tyr-D-Ser(O-tert-butyl)-Gly-Phe-Leu-Thr(O-tert-butyl), a highly selective delta opioid agonist, induces mu receptor-mediated analgesia in mice.
Baamonde A; Daugé V; Gacel G; Roques BP
J Pharmacol Exp Ther; 1991 May; 257(2):767-73. PubMed ID: 1851837
[TBL] [Abstract][Full Text] [Related]
10. Opioid receptor antagonists discriminate between presynaptic mu and delta receptors and the adenylate cyclase-coupled opioid receptor complex in the brain.
Schoffelmeer AN; De Vries TJ; Hogenboom F; Hruby VJ; Portoghese PS; Mulder AH
J Pharmacol Exp Ther; 1992 Oct; 263(1):20-4. PubMed ID: 1328606
[TBL] [Abstract][Full Text] [Related]
11. The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.
Chieng B; Connor M; Christie MJ
Mol Pharmacol; 1996 Sep; 50(3):650-5. PubMed ID: 8794906
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of adenylyl cyclase activity by the cholecystokinin analog SNF 9007 in neuroblastoma x glioma NG108-15 hybrid cells.
Roerig SC; Williams CL; Hruby VJ; Burks TF; Rosenfeld GC
Regul Pept; 1996 Jan; 61(1):51-6. PubMed ID: 8701027
[TBL] [Abstract][Full Text] [Related]
13. Unexpected antinociceptive potency of cyclic [D-Tca1]CTAP: potential for a novel mechanism of action.
Horan PJ; Wild KD; Kazmierski WM; Ferguson R; Hruby VJ; Weber SJ; Davis TP; Fang L; Knapp RJ; Yamamura HI
Eur J Pharmacol; 1993 Mar; 233(1):53-62. PubMed ID: 8386089
[TBL] [Abstract][Full Text] [Related]
14. Involvement of delta-opioid receptors in the effects induced by endogenous enkephalins on learned helplessness model.
Tejedor-Real P; Micó JA; Smadja C; Maldonado R; Roques BP; Gilbert-Rahola J
Eur J Pharmacol; 1998 Jul; 354(1):1-7. PubMed ID: 9726624
[TBL] [Abstract][Full Text] [Related]
15. SNF9007: a novel analgesic that acts simultaneously at delta 1, delta 2 and mu opioid receptors.
Williams CL; Rosenfeld GC; Dafny N; Fang SN; Hruby VJ; Bowden G; Cullinan CA; Burks TF
J Pharmacol Exp Ther; 1994 May; 269(2):750-5. PubMed ID: 8182541
[TBL] [Abstract][Full Text] [Related]
16. Use of selective antagonists and antisense oligonucleotides to evaluate the mechanisms of BUBU antinociception.
Hutcheson DM; Sánchez-Blazquez P; Rodriguez-Diaz M; Garzon J; Schmidhammer H; Borsodi A; Roques BP; Maldonado R
Eur J Pharmacol; 1999 Oct; 383(1):29-37. PubMed ID: 10556678
[TBL] [Abstract][Full Text] [Related]
17. Chronic repeated cocaine administration alters basal and opioid-regulated adenylyl cyclase activity.
Unterwald EM; Cox BM; Kreek MJ; Cote TE; Izenwasser S
Synapse; 1993 Sep; 15(1):33-8. PubMed ID: 8310423
[TBL] [Abstract][Full Text] [Related]
18. Effects of a highly selective nonpeptide delta opioid receptor agonist, TAN-67, on morphine-induced antinociception in mice.
Suzuki T; Tsuji M; Mori T; Misawa M; Endoh T; Nagase H
Life Sci; 1995; 57(2):155-68. PubMed ID: 7603296
[TBL] [Abstract][Full Text] [Related]
19. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
He L; Lee NM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
[TBL] [Abstract][Full Text] [Related]
20. A selective CCKB receptor antagonist potentiates, mu-, but not delta-opioid receptor-mediated antinociception in the formalin test.
Noble F; Blommaert A; Fournié-Zaluski MC; Roques BP
Eur J Pharmacol; 1995 Jan; 273(1-2):145-51. PubMed ID: 7737308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
